As the pharma/biopharma and biotech industries continue to evolve, the demand for cold storage is growing. Low and ultra-low temperature refrigerators, freezers, and cold spaces are critical in supporting the manufacturing, freezing, and storing of medicines, vaccines, therapeutics, biologic material, and other life science products.
Advancements in cold storage technology have expanded the variety of options to choose from, often making it difficult to identify the “just right” solution to meet the specific requirements of an application, product, or process.
Join FARRAR, a brand of Trane Technologies, on June 27 when we discuss the critical points to consider when selecting low and ultra-low temperature storage, plus the pros and cons of currently available cold storage technologies.
The primary challenges pharma and biopharma development and manufacturing organizations face are managing large volumes and adapting facility design to support the demand for critical materials.
CMOs, CDMOs, and 3PL companies have traditionally relied on ultra-low temperature (ULT) freezers to meet their process demands, having to individually fill each unit and being limited to a single set point.
As design innovations evolve, there are alternatives to the standard “freezer farm.” These solutions provide the needed flexibility, scalability, and simplified installation needed to help support optimized processes and return on investment.
Join Henry Papa, FARRAR Project Developer, to discuss how -70°C Large Scale Storage Suites can quickly scale to meet the demand of large volumes without having to adapt facility design, helping to simplify and optimize your processes.
Life sciences companies rely on cold storage solutions to protect millions of dollars of products. Temperature excursions bring risks to product viability and safety, making equipment flexibility and temperature recovery times key to preserving sample integrity, efficiency, and to the ability to deliver cutting-edge therapies.
In the past few years, the life sciences industry has been tested, and we have seen that cold storage solutions must be able to handle quick and dramatic increases in demand. At the same time, they must be energy efficient to help meet sustainability metrics.
Forced-air convection cooling assists global companies providing lifesaving therapies by reducing temperature excursions, improving equipment reliability, and increasing energy efficiency to help them meet both operational and sustainability goals.
As a pharma professional working in the GMP environment, you understand the critical importance of maintaining sample integrity, optimizing workflow, and conserving energy. Join us for our webinar on the latest advancements in cold storage technology for the pharmaceutical industry and discover how to stay ahead of the curve. Over the past decade, the demand for -60°C through -80°C assets in pharmaceutical manufacturing has skyrocketed. Clinical research investments have expanded, and commercial-scale needs continue transforming the industry. However, the lack of alternative solutions has made cold wall technology the gold standard.
But here’s the catch – cold-wall technologies were not designed or intended to perform in certain applications that are becoming increasingly common. Factors such as expedited commercialization of drug products, the need for bulk volumes, and the demand for flexible temperature setpoints have stressed traditional cold-wall systems.
Is there an alternative technology that can address these challenges? The answer is a resounding “yes.” Join us for this webinar to explore forced-air convection technology and discover how it can revolutionize your operations.
Watch this webinar on-demand to explore forced-air convection technology and discover how it can revolutionize your operations.
Balancing performance and cost is an ongoing challenge for the biopharmaceutical industry. When this is compounded by additional factors - including the scaling of complex therapeutics, global supply chain challenges, product loss, and more - it can greatly impact the ability to achieve the best return on investment and greatest process optimization.
While the challenges are complex, it is possible to attain optimal performance, operational excellence, and cost-effectiveness when the right tools are in place, supporting the development and validation of a robust freeze/thaw process that meets regulatory guidelines.
Join Entegris and FARRAR to discuss freeze/thaw technology advancements in drug product development that can help support operational excellence.
Biopharmaceutical manufacturers, CDMOs, and other life science businesses are challenged when it comes to maintaining sample viability, temperature uniformity, reliability of equipment, and application flexibility. The expectation of energy efficiency and adherence to sustainable best practices combined with these performance requirements can make equipment selection difficult and time-consuming.
The FARRARTM EcoFlex walk-in environmental chamber is ideal for those seeking a solution that checks all the boxes. With a +4°C to +37°C temperature range, built-in backup system, precise temperature and humidity control, and ease of maintenance, EcoFlex is ideal for stability testing applications.
Check out this informative discussion to learn more about the FARRAR EcoFlex walk-in environmental chamber that helps support operations and sustainability goals for both you and your customers.
The need for -60°C through -80°C assets to help future-proof manufacturing facilities has increased significantly over the past decade - clinical research investments have expanded while commercial-scale needs continue to transform the landscape.
Cold wall remains the gold standard due to a lack of alternative solutions. Several factors, however, have placed stress on cold-wall technologies to perform in applications for which they were not designed or intended. These include:
Does an alternative technology exist? The short answer is “yes.” Join us to learn more about FARRAR’s wide range of convection-cooling solutions, providing the performance and reliability you need.
The demand for freezing and cold storage solutions that provide maximum density, flexibility, and material handling that optimizes workflow and process is critical.
To help meet the needs of biopharmaceutical manufacturing, bio-logistics and clinical trial customers, FARRAR™ is excited to announce a new offering in our -20°C to -80°C ultra-cold chamber reach-in series – the ULC-259!
The new ULC-259 offers the performance customers have come to rely on and more from our ULC family of fully redundant, forced air convection style freezers.
Webinar attendees will walk away with insights on:
This webinar is ideal for individuals involved in:
Biopharmaceutical Manufacturing
Biobanking and Biorepositories
Clinical Trial Kitting
Bulk Drug Substance Manufacturing
CMO/CDMO
Cold Chain Logistics
Filled and Finished Biologic Drug Storage and Logistics
With drug manufacturing moving at an unprecedented speed, pharma and biopharma industry facility managers are struggling to align standard requirements with needs for walk-in cold chamber bulk storage construction. Deep knowledge of customer workflow and processes is critical to success.
Make sure you're up to speed on the latest industry information about the complexities of designing for low-temperature walk-in cold rooms.
Webinar attendees will walk away with insights on:
Ideal attendees include:
With drug manufacturing moving at an unprecedented speed, pharma and bio-pharma industry experts are rethinking bulk cold storage overall. Should you be as well?
• Are you challenged by poor temperature recovery from door openings?
• Do you routinely put warm drug product in freezers?
• Do you maintain empty backup freezers in case a chamber goes down?
Make sure you're up to speed on the latest industry information about the complexities of ultra-cold storage — and the latest offerings to optimize your process.
Webinar attendees will walk away with insights on:
• How to ensure temperature uniformity and fast temperature recovery
• Ways to conserve footprint while increasing yield
• A strategy for alleviating empty backup freezers
Ideal attendees include:
• Bioprocess Engineers
• Director of Operations
• Director of Manufacturing
• Procurement Leaders
• Facilities Managers
During this webinar you’ll learn more about:
.svg){kind=icon}
.webp)
© 2022 Dow Jones & Company, Inc. All rights reserved.
.jpg)
